Novo Nordisk A/S is traded on the NYSE.
Explore more US and African stocks, read the latest market news, or compare African stock exchanges on Wallflake.
Novo Nordisk A/S is traded on the NYSE. Novo Nordisk A/S operates in the Healthcare sector and trades on the New York Stock Exchange under the ticker NVO.
Novo Nordisk A/S is listed on the New York Stock Exchange, where it trades under the ticker symbol NVO. It is classified in the Healthcare sector.
NVO last traded at USD 46.50 on 4 September 2026, down 0.21% on the session. Live prices for Novo Nordisk A/S update through the trading day on Wallflake.
Novo Nordisk A/S has a market capitalisation of approximately USD 206.02B, based on its closing price on 4 September 2026.
Over the past 52 weeks NVO has traded between a low of USD 35.12 and a high of USD 64.16.
Yes. Novo Nordisk A/S pays a dividend, with a trailing yield of 3.78%. Its payout ratio is approximately 44.46%.
NVO has a price-to-earnings (P/E) ratio of 11.68 and earnings per share (EPS) of USD 3.99. These figures are reported metrics, not a valuation opinion — Wallflake does not issue buy, sell or hold recommendations.
NVO shares are bought and sold through a broker licensed to trade on the New York Stock Exchange. You open an account with a licensed broker, fund it, and place an order quoting the ticker NVO. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our New York Stock Exchange guide for how the market works. Read the guide
Figures are drawn from Wallflake's market data and are provided for information only. Nothing here is investment advice or a recommendation to buy or sell any security.